Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Amphibian may hold key to curing cirrhosis
The liver of the Siphonops annulatus could help to cure cirrhosis in humans.

Unique liver cells break down the protein collagen

A South American amphibian could hold the key to curing cirrhosis, according to new research.

Researchers found the liver of Siphonops annulatus contains unique liver cells - known as melanomacrophages - which can remove and break down the protein collagen. In turn, this helps to minimise unwanted inflammation and reduce scar tissue which can lead to cirrhosis.

Study author Dr Augusto Coppi from the University of Surrey said: “The liver function of this amphibian, Siphonops annulatus, may provide us with a unique opportunity to solve one of the most devastating illnesses of the liver.

“We do need further in-depth investigations into how this discovery can be translated into humans, but it may have the potential to alter how we view and treat this disease.”

Cirrhosis occurs in response to liver damage. Hepatitis, chronic alcoholism or other harmful substances can all prompt the response of self-repair in the liver, which manifests as a high production of collagen and scar tissue.

As the condition progresses, liver functions such as cleaning blood become difficult. Several treatment strategies for cirrhosis have been attempted across the world including delaying or removing the underlying stimulus that causes scar tissue to form.

Dr Robson Gutierre from the Federal University of Sao Paulo said: “The ability this species has to break down its natural defences could also provide insight into immunity tolerance, a mechanism by which the liver can minimise unwanted inflammations.

"|mmunity tolerance can be studied in this species because they produce pro-inflammatory cells in the hematopoietic liver throughout its whole life, without developing chronic inflammations.”
 
The study, Melanomacrophage functions in the liver of the caecilian Siphonops annulatus, is published in The Journal of Anatomy.

Image (C) Andreas Schlüter

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.